J01DD02 • ceftazidime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins
Ceftazidime is a third-generation cephalosporin antibiotic used to treat severe bacterial infections, including pneumonia, intra-abdominal infections, complicated urinary tract infections, and sepsis. It is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa.
The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Ceftazidime is primarily used in hospitals for complicated infections or for patients at high risk of severe infections.
Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or renal toxicity. It is important for patients to complete the treatment as directed by their doctor.
Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as encephalopathy or seizures. Patients should inform their doctor of any unusual symptoms.
Substance: ceftazidime
Date of last drug list: 01-06-2016
Commercial code: W62472004
Concentration: 2g
Pharmaceutical form: powder for injection / infusion solution
Quantity: 25
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).